glp-1 rheumatoid arthritis study Glucagon-like peptide and its receptor agonists for the treatment of rheumatic diseases The GLP-1 agonist, liraglutide, ameliorates

Now, researchers are exploring new iterations, including oral versions and multi-pathway therapies

Muscle-preserving strategies, exercise, adequate protein (~1.2-1.6 g/kg/d), creatine, and promising new agents like #bimagrumab and myostatin inhibitors

Visit our media relations page to view contact information for public relations personnel

About Obesity Obesity is recognised as the greatest single risk factor for chronic disease globally

Melissa June 15, 2026 Return policy 4.6 (38.3K) (2K) (3.7K) (990) (3K) (5.3K) (479) (1.9K) (299) (382) (67) (1.7K) (170) 4.8 (105.9K) (2.6K) (2.2K) (19K) (1.6K) (1.5K) (2.5K) (1.3K) (962) 4.7 (588) (147) (10) (14) (20) (44) (5) (41) (28) (16) (11) (53.2K) 20% off (169) (488) 18% off (84) (7.4K) (215) (5.5K) (256) (242) 26% off (514) (1.4K) 4.6 (250) (926) (585) (164) (34) (207) (149) (32) (52) (97) 4.6 (117.7K) 4.7 (10.6K) 4.6 (452.5K) 4.5 (179.9K) 4.9 (532.1K) 4.5 (94.5K) 4.9 (34.5K) 4.7 (174.2K) 4.4 (9.5K) 4.3 (428.8K)